Duke Capital: Unlocking growth with strategic equity raise

Hardman & Co
[shareaholic app="share_buttons" id_name="post_below_content"]

In our April 2024 initiation, we highlighted that Duke Capital plc (LON:DUKE), by optimising the best of equity and debt, aimed to achieve equity-type returns with debt levels of risk. We highlighted four pillars of returns, namely: i) term credit; ii) participating preference shares, which support the company’s high, covered and growing dividend yield (2025E 10.0%, 2026E 10.7%, 2027E 11.4%); iii) early exit fees; and iv) equity stakes. Here, we update investors on how management will take the gorup to the next level, noting i) a £20.2m+ equity issue to fund short-term growth, and ii) the progress made towards a third-party capital model, negating the need for further raises.

  • Equity raise: Instead of the £40m raise we had been forecasting in FY’26, Duke Capital seeks to raise £20.2m+ now, and indicates greater confidence that further issues will not be necessary. The risk of dilution is thus lower than it was before this announcement. The current raise is to fund expected client buy-and-build deals.
  • Third-party capital model: Using third-party capital potentially brings revenue, gearing, risk, liquidity, capital and income benefits. The constraint, to date, has been that DUKE’s innovative product was little known. As a track record has been built, confidence has grown, and DUKE has made significant progress.
  • Valuation: The FY’25E dividend yield is 10.0%. On the assumptions outlined in the initiation report, our valuation approaches indicate GGM 44.2p, discounted cashflow 72.3p, and dividend discount 43.1p, with an average of 53.2p against the current share price of 28.1p.
  • Risks: Counterparty risk is core to any finance provider. Currently, there is adverse sentiment to most speciality finance businesses. We see a short-term dependence on key staff. Many investors are unfamiliar with the product, there are few comparators, and the underlying assets are likely to be illiquid.
  • Investment summary: By having a unique proposition, which adds value to clients, and with high barriers to entry, Duke Capital is able to generate strong returns and thus pay a high, consistent dividend. The way the product is structured provides multiple levers for both income and capital growth, as well as limiting the downside risk. DUKE has invested in new staff in FY’24 to optimise the opportunity while showing good discipline in the pacing of new investments.
Share on:
Find more news, interviews, share price & company profile here for:

UK SMEs poised for growth as recession fears ease

UK SMEs are gearing up for growth as recession fears ease, leading to a surge in demand for business loans.

Duke Capital deepens stake in Tristone Healthcare

Duke Capital has made a £2.5 million investment in Tristone Healthcare, enhancing its role in the specialist care sector and expanding support for young individuals in need.

Duke Capital backs Tristone’s Serenity acquisition

Duke Capital Limited has announced a £2m follow-on investment in Tristone Healthcare, enhancing its growth strategy in the social care sector across Europe and North America.

UK SME lending gains momentum

The UK SME lending landscape is reviving as businesses seek finance to drive growth. Explore how enhanced funding options empower SMEs for success.

How SMEs can harness alternative finance to thrive

UK SMEs face a pivotal moment as traditional financing dwindles. Explore how alternative lenders are reshaping funding options and boosting growth potential.

Search

Search